Hair loss abstract
The present invention is directed to a natural formulation for
treatment of male pattern hair loss. The formulation contains a
combination of Saw Palmetto extract, African Pygeum extract, stinging
nettle extract, and optionally zinc, vitamin B6 and green tea extract.
The various extracts are prepared according to the traditional procedures,
then combined in a suitable formulation for administration to the
patient for treatment of the male pattern hair loss.
Hair loss claims
The embodiments of the invention in which an exclusive property
or privilege is claimed are defined as follows:
1. A natural formulation for treatment of male pattern hair loss,
the formulation comprising a combination of Saw Palmetto extract,
African Pygeum extract, and stinging nettle extract.
2. A formulation according to claim 1 wherein the formulation further
comprises one or more other ingredients selected from natural herbal
extracts, minerals and vitamins.
3. A formulation according to claim 2 wherein the one or more other
ingredients are green tea extract, zinc salt and vitamin B6.
4. A formulation according to claim 3 wherein the formulation comprises:
5. A formulation according to claim 4 wherein the formulation comprises:
6. A formulation according to claim 5 wherein the formulation comprises:
Hair loss description
FIELD OF THE INVENTION
The present invention is directed to a preparation for treatment
of male pattern hair loss, and in particular, to a natural herbal
and mineral preparation to help stop further hair loss and increase
hair growth in a person having male pattern hair loss.
BACKGROUND OF THE INVENTION
Human hair undergoes a normal growth cycle where each hair grows
continuously for approximately 2 to 4 years, and stops growing for
2 to 4 months, and then falls out. In its place, a new healthy hair
begins to grow and this cycle is repeated. The hairs on the head
are always in different stages of the cycle, so it is normal to
loose scalp hair everyday. On average, up to about 100 hairs is
lost per day.
In male pattern hair loss, the normal hair growth cycle is disrupted
and more than the average number of hairs are shed per day without
having the old hairs replaced by new ones. Male pattern hair loss
is determined by a combination of male hormones (androgens) and
heredity. Men susceptible to male pattern baldness usually experience
the onset sometime in their 20's and it becomes more common as they
age. Androgenetic alopecia is the most common type of hair loss
in men, with approximately 50% of men experiencing this hair loss
to some degree by the age of 50.
In addition to adrogenetic alopecia, other factors may influence
hair loss, many of which are temporary. Amongst these factors include
stress of an illness or major surgery, medicines, such as those
used in chemotherapy, blood thinners, antidepressants, excessive
amounts of vitamin A and certain disease states like diabetes.
There is increasing evidence of the link between male pattern hair
loss and the level of 5 alpha-reductase. 5 alpha-reductase converts
the hormone testosterone into dihydrotestosterone (DHT). There have
been many reports of men with male pattern hair loss having increased
levels of DHT in the scalp. It appears that DHT contributes to the
shortening of the growth phase and thinning of the hair.
A number of preparations have recently been proposed for treating
male pattern hair loss, of which the most well known is Minoxidil.
Minoxidil is applied topically to the scalp and has been shown to
stimulate hair growth in individuals with androgenetic alopecia.
The exact mechanism of the action of Minoxidil in the treatment
is not know, and it is thought that there is more than one mechanism
by which Minoxidil stimulates hair growth. Some of the mechanisms
by which Minoxidil may stimulate hair growth include phasodilation
of the micro circulation around the hair follicles, which may stimulate
hair growth; direct stimulation of the hair follicle cells to enter
into a peripheral phase whereby resting phase follicles are stimulated
to pass into active phase folicles; or alteration of the effect
of androgens on genetically predetermined hair follicles. It was
thought that Minoxidil might affect the androgen metabolism in the
scalp, inhibiting the capacity of androgens to affect the hair follicles.
Another medication utilized for treatment of adrogenetic alopecia
is Finisteride. Finisteride is an inhibitor of type II 5-alpha-reductase
and has been shown to be effective in decreasing scalp DHT by inhibiting
conversion of testosterone to DHT. Oral administration of Finisteride
slowed hair loss, increased hair growth and improved the appearance
of hair.
5-alpha-reductase enzyme has also been linked to benign prostatic
hyperplasia. A number of the medications now utilized for treating
the male pattern hair loss were originally developed for treatment
of benign prostatic hyperplasia.
Recently, there has been increased interest in the use of natural
therapy for treatment of a diseased state. A number of herbal extracts
have been demonstrated to be useful in the treatment of benign prostatic
hyperplasia. Once such herbal extract is the extract of the berries
of Saw Palmetto. Saw Palmetto is a small palm tree with large leaves
and large deep red black berries. Saw Palmetto berries contain an
oil with a variety of fatty acids and phytosterols. The fat soluble
extract of Saw Palmetto berries has been shown to inhibit the conversion
of testosterone, which is thought to be responsible for the enlargement
of the prostrate. In addition, Saw Palmetto extract inhibits the
binding of DHT to receptors, thus blocking DHT's action and promoting
the breakdown of the potent compound. Another herbal extract utilized
is African Pygeum. Pygeum is a large evergreen tree growing in the
higher plateaus of southern Africa. The bark of the tree is processed
to produce a fat-soluble fraction, which contains phytosterols,
pentacyclic triterpenoids and ferulics esters of long chain fatty
acids. African Pygeum extracts in double blind clinical trials have
been found to be effective in treating a wide range of prostatic
hyperplasia. Consumption of Pygeum extract resulted in a significant
amelioration of symptoms, reduction in prostate size and clearance
of bladder neck urethral obstruction.
Stinging nettles extract, which are an extract of a perennial plant
growing worldwide, have been demonstrated to show a reduction in
prostatic growth potential in mice with the administration of a
high dosage of the nettle root extract. Stinging nettles have also
been traditionally been known as a hair and skin tonic, stimulating
hair growth, improving condition of the hair and skin and treating
dandruff.
There still remains a need for a natural hair growth stimulant
for use in treating androgenetic alopecia, having reduced side effects
and risk of toxicity compared with synthesized pharmaceutical compounds.
SUMMARY OF THE INVENTION
In one aspect, the present invention provides for a composition
for treating male pattern hair loss. The composition comprises Saw
Palmetto extract, African Pygeum extract, stinging nettle extract,
and optionally minerals, vitamins and other natural extracts.
In an aspect of the invention, the optional minerals, vitamins
and other extracts include zinc salts, vitamin B6 and green tea
extract.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention is directed to a natural formulation for
treatment of male pattern hair loss. The formulation contains a
combination of Saw Palmetto extract, African Pygeum extract, stinging
nettle extract. The various extracts are prepared according to the
traditional procedures, then combined in a suitable formulation
for administration to the patient for treatment of the male pattern
hair loss.
The Saw Palmetto extract is a extract of the berries of the Saw
Palmetto tree, which is a small palm tree with large leaves and
large deep red black berries. The Saw Palmetto extract is a purified
fat-soluble extract prepared by extracting the fat-soluble components
of the berries. These components include steroidal saponins, fatty
acids, phytosterols, volatile oil, resins and tannins. The Saw Palmetto
berries contain an oil with a variety of fatty acids and phytosterols.
The fatty acids include capric, caprylic, caproic, lauric, palmitic
and oleic acid and ethyl esters. The major phytosterols found in
Saw Palmetto berries include beta-sitosterol, stigmasteriol, cycloartenol,
lupcol, lupenone and 24-methyl-cycloartenol.
The African Pygeum extract is an extract of the air-dried bark
from the trunk of the Pygeum africanum. Pygeum africanum is a large
evergreen tree growing in the higher plateaus of southern Africa.
The bark is collected and powdered, passed through a screen and
extracted with chloroform to isolate the fat-soluble fractions.
The lipophilic extracts are filtered and concentrated to dryness
under vacuum until complete elimination of the chlorinated solvent.
The African Pygeum extract contains three groups of active compounds.
Phytosterols, such as beta-sitosterol, pentacyclic triterpenoids,
such as ursolic and oleanic acids and ferulic esters of fatty alcohols,
particularly the ferulic esters of docosanol and tetracosanol.
The stinging nettle extract are prepared from the young top leaves
of stinging nettle plants. The top leaves are harvested from plants
grown in clean, uncontaminated areas. The leaves are dried and powdered,
then extracted with water and alcohol. The extract is concentrated
to a paste and spray dried to produce a stable pure powder. The
stinging nettle extract contains formic acid, histamine, acetylcholine,
5-hydroxy tryptamine, glucoquinones, minerals (including iron, magnesium,
silica, potassium, sulfur), vitamins A, C, B2 and B5 and chlorophyll.
In addition to the above extracts, the formulation of the present
invention may also include minerals, vitamins, or other natural
extracts. Preferably, the optional minerals, vitamins and other
extracts include zinc, vitamin B6 and green tea extract.
The zinc is preferably provided as a zinc salt, such as zinc acetate,
zinc gluconate, zinc oxide or zinc sterate. Most preferably the
zinc salt is the salt sold under the trademark OPTIZINC.
The optional vitamins used in the formulations may be any of the
commonly used vitamins. Preferably, the vitamin, most preferably
vitamin B6.
The green tea extract is a typical extract prepared from green
tea leaves.
The formulations of the present invention may be provided in any
form, which will be suitable for administration to the patient.
While the formulation may be provided as a topical formulation for
direct application to the scalp, it is preferred if the formulation
is provided in a form suitable for oral administration to the patient.
Thus, the formulation may be provided as preferrably, the solid
formulations or tablets or capsules, most preferrably capsules.
The oral formulations may be in the form of a liquid or solid formulation.
Liquid formulations may include syrups, teas, etc., while the solid
formulations may include powders, tablets and capsules.
The amount of each of the individual components present in the
formulation is selective for optimum therapeutic effect. Preferrably,
the formulation contains the following amounts of the active ingredients:
______________________________________ Saw Palmetto extract 100-320
mg Pygeum Africanum Extract 25-100 mg Urtica Dioica Extract 50-200
mg Zinc 5-15 mg Vitamin B6 25-75 mg Green Tea Extract 50-200 mg
______________________________________
More preferrably, the formulation contains:
______________________________________ Saw Palmetto extract 125-200
mg Pygeum Africanum Extract 40-75 mg Urtica Dioica Extract 75-150
mg Zinc 7-12 mg Vitamin B6 40-60 mg Green Tea Extract 75-140 mg
______________________________________
Most preferrably, the formulation contains:
______________________________________ Saw Palmetto Extract 160
mg Pygeum Africanum Extract 50 mg Urtica Dioica Extract 120 mg Zinc
10 mg Vitamin B6 50 mg Green Tea Extract 105 mg ______________________________________
As noted above, the formulations for oral administration may be
in the form of tablets or capsules. For tabletting, the active ingredients
may be combined with typical excipients utilized in preparing tablets,
such as binders and other tabletting agents. If prepared as capsules,
the combined powdered ingredients will be filled into standard gelatin
capsules and sealed.
The usual daily dose of the formulation of the present invention
will comprise between:
______________________________________ 200-500 mg Saw Palmetto
Extract 50-200 mg Pygeum Africanum Extract 100-400 mg Urtica Dioica
Extract 10-30 mg Zinc 50-150 mg Vitamin B6 100-400 mg Green Tea
Extract ______________________________________
More preferrably, the usual daily dosage will comprise:
______________________________________ 250-400 mg Saw Palmetto
Extract 80-150 mg Pygeum Africanum Extract 150-300 mg Urtica Dioica
Extract 15-25 mg Zinc 80-120 mg Vitamin B6 150-280 mg Green Tea
Extract ______________________________________
For most treatment, the optimum daily dosage is:
______________________________________ 320 mg Saw Palmetto Extract
100 mg Pygeum Africanum Extract 240 mg Urtica Dioica Extract 20
mg Zinc 100 mg Vitamin B6 210 mg Green Tea Extract ______________________________________
This dosage is ideally administered by administering two capsules,
each containing the preferred formulation as set out above.
The formulations of the present invention are thought to affect
male pattern hair loss through interaction with the production of
dihydrotestosterone in the scalp. It is thought that the formulations
of the present invention lock 5-alpha-reductase, the enzyme involved
in the production of dihydrotestosterone from testosterone. Through
this blockage of the 5-alpha-reductase, the level of dihydrotestosterone
in the scalp is decreased, leading to the normalization of the hair
growth cycle and the reversal of hair loss process normally associated
with male pattern hair loss. The effects of the formulations of
the present invention may not be immediately apparent. The formulation
must be taken regularly in order to obtain maximum benefit.
Although various preferred embodiments of the present invention
have been described herein in detail, it will be appreciated by
those skilled in the art, that variations may be made thereto without
departing from the spirit of the invention or the scope of the appended
claims. |